Niclosamide

CSIR India and Laxai Life Sciences initiate clinical trials of promising repurposed drug Niclosamide for treatment of Covid-19

CSIR in collaboration with Laxai Life Sciences Pvt. Ltd., has initiated Phase-II clinical trial with anti-helminitic drug Niclosamide for treatment…

Read More »